Brief: Nordic Nanovector To Conduct A Comprehensive Review

Thor Medical ASA

02/06/2022 06:06

June 2 (Reuters) - Nordic Nanovector ASA  NANOVN.OL :
    * TO CONDUCT A COMPREHENSIVE REVIEW AND INDEPENDENT DATA
    * AS HIGHLIGHTED AT RECENT Q1 RESULTS, REPORTED ON 13 MAY
2022,
RECRUITMENT INTO PARADIGME HAS BEEN SLOWER THAN ANTICIPATED, AND
DESPITE ONGOING EFFORTS BY COMPANY THIS HAS CONTINUED INTO Q2
WITH NO ADDITIONAL PATIENTS ENROLLED IN MAY
    * AS A RESULT, BOARD OF NORDIC NANOVECTOR HAS DECIDED TO
CONDUCT A
COMPREHENSIVE REVIEW OF ALL ASPECTS OF PARADIGME STUDY
    * CURRENT GUIDANCE FOR DELIVERY OF INITIAL TOP LINE DATA
FROM
PARADIGME IN SECOND HALF OF THIS YEAR WILL BE REVIEWED
CONCURRENTLY
    * BOARD EXPECTS TO REPORT ON FINDINGS OF REVIEW OF PARADIGME
NO
LATER THAN Q2 RESULTS TO BE RELEASED ON 20 JULY 2022 AND WILL
NOT BE COMMENTING FURTHER UNTIL REVIEW IS COMPLETE

Source text for Eikon:  ID:nObiD4tjJa 
Further company coverage:  NANOVN.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))